Literature DB >> 9853211

MRI of bone metastases.

D Vanel1, J Bittoun, A Tardivon.   

Abstract

Some knowledge of MR theory is required to be able to achieve high contrast between bone metastases and normal marrow. Three factors are used in MR to diagnose bone metastases; fat-water distribution, artifacts induced by bone trabeculae, and uptake of contrast medium. Using MR-histological correlations based on specimens of the lumbar spine, and studies of patients, we explain the advantages and limitations of sequences studying fat and water (spin-echo T1, STIR, in- and out-of-phase gradient echo, fat presaturation), bone trabeculae (gradient echo with long TE), and the injection of contrast medium.

Entities:  

Mesh:

Year:  1998        PMID: 9853211     DOI: 10.1007/s003300050549

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  17 in total

1.  Cost comparison analysis of low-field (0.23 T) MRI- and CT-guided bone biopsies.

Authors:  J Alanen; L Keski-Nisula; R Blanco-Sequeiros; O Tervonen
Journal:  Eur Radiol       Date:  2003-06-25       Impact factor: 5.315

Review 2.  Magnetic resonance imaging of bone marrow in oncology, Part 1.

Authors:  Sinchun Hwang; David M Panicek
Journal:  Skeletal Radiol       Date:  2007-05-11       Impact factor: 2.199

Review 3.  Metastasis to nervous system: spinal epidural and intramedullary metastases.

Authors:  Melike Mut; David Schiff; Mark E Shaffrey
Journal:  J Neurooncol       Date:  2005-10       Impact factor: 4.130

4.  Is there a need for contrast-enhanced T1-weighted MRI of the spine after inconspicuous short tau inversion recovery imaging?

Authors:  Andreas H Mahnken; Joachim E Wildberger; Gerhard Adam; Sven Stanzel; Thomas Schmitz-Rode; Rolf W Günther; Arno Buecker
Journal:  Eur Radiol       Date:  2005-03-18       Impact factor: 5.315

5.  Value of a Dixon-based MR/PET attenuation correction sequence for the localization and evaluation of PET-positive lesions.

Authors:  Matthias Eiber; Axel Martinez-Möller; Michael Souvatzoglou; Konstantin Holzapfel; Anja Pickhard; Dennys Löffelbein; Ivan Santi; Ernst J Rummeny; Sibylle Ziegler; Markus Schwaiger; Stephan G Nekolla; Ambros J Beer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-06-18       Impact factor: 9.236

6.  Screening for bone metastases: whole-body MRI using a 32-channel system versus dual-modality PET-CT.

Authors:  Gerwin P Schmidt; Stefan O Schoenberg; Rupert Schmid; Robert Stahl; Reinhold Tiling; Christoph R Becker; Maximilian F Reiser; Andrea Baur-Melnyk
Journal:  Eur Radiol       Date:  2006-09-02       Impact factor: 5.315

7.  Early detection with MRI of incomplete treatment of spine metastases after percutaneous cryoablation.

Authors:  Guillaume Gravel; Lambros Tselikas; Benjamin Moulin; Steven Yevich; Eric Baudin; Antoine Hakime; Salma Moalla; Fadila Mihoubi; Corinne Balleyguier; Thierry de Baere; Frederic Deschamps
Journal:  Eur Radiol       Date:  2019-03-15       Impact factor: 5.315

Review 8.  Metastatic disease of the spine.

Authors:  Cosma Andreula; Mario Murrone
Journal:  Eur Radiol       Date:  2005-02-05       Impact factor: 5.315

9.  Comparison of whole-body MRI with automatic moving table technique and bone scintigraphy for screening for bone metastases in patients with breast cancer.

Authors:  K Engelhard; H P Hollenbach; K Wohlfart; E von Imhoff; F A Fellner
Journal:  Eur Radiol       Date:  2003-07-05       Impact factor: 5.315

10.  Whole-body MRI at 1.5 T and 3 T compared with FDG-PET-CT for the detection of tumour recurrence in patients with colorectal cancer.

Authors:  G P Schmidt; A Baur-Melnyk; A Haug; S Utzschneider; C R Becker; R Tiling; M F Reiser; K A Hermann
Journal:  Eur Radiol       Date:  2009-02-04       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.